FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30767311000001107: Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Oct 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
94173801000001118 Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94173901000001112 Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Is a Magnesium oxide 160mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Has AMP Magdose 160mg tablets (TriOn Pharma Ltd) true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Has specific active ingredient Magnesium oxide true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Legal category Legal category not applicable true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start